Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the...
24 Jun 2020 9:16 AM IST
The drugmaker is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions
27 May 2021 12:19 PM IST